<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did NEUE's Q1 2025 EPS forecast compare to past trends?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/8/2025 07:47pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">NEUE's Q1 2025 EPS forecast of -$3.19 with a range of -$4.18 to -$2.20, compared to the previous quarter's EPS of -$7.41, suggests a significant improvement in profitability. This is a notable positive trend indicating a potential turnaround or stabilization in the company's financial performance. However, it is important to note that NEUE has a history of volatile EPS results, with a significant beat of EPS estimates 25.00% of the time in the past 12 months. This suggests that while there is a positive trend, it is important to monitor the company's performance closely and consider the broader context of its financial performance over time.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an){return {layout:"default",data:[{noData:c,currentQuestion:d,textDescription:D,comeFrom:"AInvestShareLink",events:[],answerSource:l}],fetch:{},error:m,state:{sharePreviewModule:{loadJgySuccess:g,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:l,cache_builder:a,reply_action:"Answer",execute_mode:u,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did NEUE's Q1 2025 EPS forecast compare to past trends?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did NEUE's Q1 2025 EPS forecast compare to past trends?\",\"user_id\":\"dp11087230\",\"user_name\":\"\",\"trace_id\":\"bf2b3dd0-c917-4e18-88ba-7b3197c3c94f\",\"session_id\":\"bf2b3dd0-c917-4e18-88ba-7b3197c3c94f\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"search",raw_data:{number:E,title:F,summary:G,full_summary:"NEUE Financial Forecast NEUE Earnings Forecast Next quarter’s earnings estimate for NEUE is -$3.19 with a range of -$4.18 to -$2.20. The previous quarter’s EPS was -$7.41. NEUE beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.40% of the time in the same period. In the last calendar year NEUE has Outperformed its overall industry. read more Next quarter’s earnings estimate for NEUE is -$3.19 with a range of -$4.18 to -$2.20. The previous quarter’s EPS was -$7.41. NEUE beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.40% of the time in the same period. In the last calendar year NEUE has Outperformed its overall industry. NEUE Sales Forecast Next quarter’s sales forecast for NEUE is $316.00M with a range of $270.10M to $361.90M. The previous quarter’s sales results were $232.64M. NEUE beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.66% of the time in the same period. In the last calendar year NEUE has Outperformed its overall industry. read more Next quarter’s sales forecast for NEUE is $316.00M with a range of $270.10M to $361.90M. The previous quarter’s sales results were $232.64M. NEUE beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.66% of the time in the same period. In the last calendar year NEUE has Outperformed its overall industry. Detailed List of Analyst Forecasts Detailed List of Analyst Forecasts Analyst Profile Expert Firm Price Target Position Upside \u002F Downside Action Date Follow Article RBC Capital $7 Hold 44.63% Upside Reiterated 12\u002F08\u002F24 0 0 Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NYSE: NEUE), Agilent (NYSE: A) and Legend Biotech (NASDAQ: LEGN) Ranks Any Any Analyst Rating Any Any Upside\u002F Downside Any Any Action Any Any Analyst Profile Expert Firm Price Target Position",url:H,image_url:a,video_url:a,publish_time:I,search_extra_info:{search_burial_info:{id:J,uid:v,ab:{scene_id:K,layer_exp:[{layer_id:L,exp_id:M}]}}},simhash:"e34107776ac1bcce",msg_id:v}}],answer_chain_name:N,agent_mode:O,native_answer:a,come_from:a,text_answer:D,trace_id:e,cost:19031,event_names:a,question:d,fallback_type:P,input_type:Q,fall_back_reason:{fall_back_type:P,risk_detail:{matched_words:[]}},session_id:e,first_return_cost:3132,cache_type:a,question_id:e,transfer_question:d,signal_type:"ON_COMPLETE",start_time:R,remote_svc:l,slots:[],answer_type:u,user_id:r,skill_name:w},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:e,session_id:e,user_id:r,question:d,source:l,raw_question:d,version:"3.4.1",action_name:w,nlu:{entity:[{type:S,value:"NEUE.N",market:T}]},deep_research:c,deep_thinking:c,agent_mode:O},extra:{}},{answer_path:h,section:{id:i,info_texts:["Thinking"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:h,section:{id:i,info_texts:["Querying Stock: NEUE Q1 2025 EPS Forecast, 5-Year EPS CAGR"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:"Querying Stock",action_input:"NEUE Q1 2025 EPS Forecast, 5-Year EPS CAGR",thought:"The user wants to compare NEUE's Q1 2025 EPS forecast with its past trend. I should focus on collecting the Q1 2025 EPS forecast and historical EPS data. I will use FinQuery for the data mentioned above."}},{answer_path:f,section:{id:y,info_texts:[],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Searching Web: NeuHealth Q1 2025 EPS Forecast"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:U,action_input:"NeuHealth Q1 2025 EPS Forecast",thought:V}},{answer_path:h,section:{id:i,info_texts:["Searching Web: NeuHealth EPS"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:x},logs:[],extra:{action:U,action_input:"NeuHealth EPS",thought:V}},{answer_path:f,section:{id:y,info_texts:[],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:f,section:{id:y,info_texts:[],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Generating Answer"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:f,section:{id:z,info_texts:[],show_type:A,voice_txt:"NE",text_answer:W,rich_text:W,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:f,section:{id:2000,info_texts:[],show_type:A,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:H,image_url:a,video_url:a,title:F,summary:G,index:E,publish_time:I,search_id:J,search_uid:v,search_ab:{scene_id:K,layer_exp:[{layer_id:L,exp_id:M}]},jump_type:"normal"}],is_last:b},logs:[],extra:{}},{answer_path:f,section:{id:z,info_texts:[],show_type:A,voice_txt:". This",text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:f,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:Y,market_id:T,name:"NeueHealth",domain:S},pos:g,section_id:z,txt:Y,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:h,section:{id:i,info_texts:["Completed"],show_type:j,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:n,query_text:n,trace_info:{item_id:"d9495943997baaeb3d469881cae1585d",item_type:k,item_name:n,rec_info:Z}},{display_text:o,query_text:o,trace_info:{item_id:"a6457872730935ce9a49d306b1288df2",item_type:k,item_name:o,rec_info:_}},{display_text:p,query_text:p,trace_info:{item_id:"ebf2207ea49fe821a4e69febd89f3942",item_type:k,item_name:p,rec_info:$}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:c,txt_style:g,type:"1",display2:c,url:a}},request_config:[{source_type:aa,related_name:ab}],puuid:B,tag:a,category:"custom",uuid:ac}],global:{urp_static_data:[{name:ab,value:{status_code:g,columns:[{type:q,index_name:ad,key:ad},{type:q,index_name:ae,key:ae},{type:q,index_name:af,key:af},{type:q,index_name:ag,key:ag},{type:q,index_name:ah,key:ah}],datas:[{send_text:n,item_type:k,rec_info:Z,display_text:n,rec_reason:a},{send_text:o,item_type:k,rec_info:_,display_text:o,rec_reason:a},{send_text:p,item_type:k,rec_info:$,display_text:p,rec_reason:a}],dataSize:aa,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:ai,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:t,"min-height":"100%",position:aj,height:t},isMaterial:c,id:ai,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:g,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:C,componentUuid:ac,script:[{name:ak,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:C,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:C},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:t,position:aj,height:t},isMaterial:b,_id:19,id:ak,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:al,voice_txt:a,tracking_info:{},uuid:B},order:{is_auto:c,render_for:al,chart_type:"command",puuid:B}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:s,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:w,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:u,answer_chain_name:N},is_deep_research:c,deep_thinking:c,create_time:1744112845164},is_last:b}],questionItem:{data:{qStr:d,encodeFlag:c,imageData:m,docsData:[],quoteData:m},tplType:"question"},events:am,agentId:a,param:{entity_info:{},add_info:{ori_question:d},event_list:am,client_ip:a,question:d,user_id:r,user_name:a,trace_id:e,session_id:e,source:l,input_type:Q}}],userId:r,userName:a,startTime:R,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:m,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:g,traceTableData:m,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fneues-q1-2025-eps-forecast-compare-trends-53bee7\u002F",config:{_app:{basePath:an,assetsPath:an,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"How did NEUE's Q1 2025 EPS forecast compare to past trends?","bf2b3dd0-c917-4e18-88ba-7b3197c3c94f","other\u002FopenAnswer",0,"progress\u002Fsearching_for",1000,"searching_for","llm_generated","ths_ainvest_lite_web",null,"How have NEUE's EPS forecasts evolved over the past five quarters?","What are the current analyst estimates for NEUE's Q1 2025 EPS?","What are the key factors influencing NEUE's EPS forecasts for Q1 2025?","STR","dp11087230","signal","auto","agent","566f5bd68dd46e05","review stocks","thinking",999,2001,"rich_text","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","NEUE's Q1 2025 EPS forecast of -$3.19 with a range of -$4.18 to -$2.20, compared to the previous quarter's EPS of -$7.41, suggests a significant improvement in profitability. This is a notable positive trend indicating a potential turnaround or stabilization in the company's financial performance. However, it is important to note that NEUE has a history of volatile EPS results, with a significant beat of EPS estimates 25.00% of the time in the past 12 months. This suggests that while there is a positive trend, it is important to monitor the company's performance closely and consider the broader context of its financial performance over time.",4,"NeueHealth Inc (NEUE) Stock Forecast & Price Target","NEUE Financial Forecast NEUE Earnings Forecast Next quarter’s earnings estimate for NEUE is -$3.19 with a range of -$4.18 to -$2.20. The previous quarter’s EPS was -$7.41. NEUE beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.40% of ...","https:\u002F\u002Fwww.tipranks.com\u002Fstocks\u002Fneue\u002Fforecast","2025-03-21","566f5bd68dd46e05_0","oeqxkhszf","oeqxkhszf_layer","base","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744112826134,"stock","169","Searching Web","I am unable to obtain NEUE's Q1 2025 EPS forecast and historical EPS data using FinQuery, now I will try again using Search tool.","NEUE's Q1 2025 EPS forecast of -$3.19 with a range of -$4.18 to -$2.20, compared to the previous quarter's EPS of -$7.41, suggests a significant improvement in profitability[^4]",". This is a notable positive trend indicating a potential turnaround or stabilization in the company's financial performance. However, it is important to note that NEUE has a history of volatile EPS results, with a significant beat of EPS estimates 25.00% of the time in the past 12 months[^4]. This suggests that while there is a positive trend, it is important to monitor the company's performance closely and consider the broader context of its financial performance over time.","NEUE","2+679_496_21_554+0+0+bf2b3dd0-c917-4e18-88ba-7b3197c3c94f+d9495943997baaeb3d469881cae1585d+llm_generated+aimeTagAnalysis+0+0.07830808311700821+1","2+679_496_21_554+0+0+bf2b3dd0-c917-4e18-88ba-7b3197c3c94f+a6457872730935ce9a49d306b1288df2+llm_generated+aimeTagAnalysis+0+0.07400259375572205+2","2+679_496_21_554+0+0+bf2b3dd0-c917-4e18-88ba-7b3197c3c94f+ebf2207ea49fe821a4e69febd89f3942+llm_generated+aimeTagAnalysis+0+0.050901126116514206+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>